Dieleman JP - Search Results

1

Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study.

Trifirò G, Mokhles MM, Dieleman JP, van Soest EM, Verhamme K, Mazzaglia G, Herings R, de Luise C, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, van Camp G, Zanettini R, Sturkenboom MC. Trifirò G, et al. Among authors: dieleman jp. Drug Saf. 2012 Feb 1;35(2):159-71. doi: 10.2165/11594940-000000000-00000. Drug Saf. 2012. PMID: 22204718

2

[Lipodystrophy and 'buffalo hump' during treatment with HIV protease inhibitors].

Dieleman JP, Hillebrand-Haverkort ME, van der Ende ME, Sturkenboom MC, Lange JM, Stricker BH. Dieleman JP, et al. Ned Tijdschr Geneeskd. 1998 Dec 26;142(52):2856-60. Ned Tijdschr Geneeskd. 1998. PMID: 10065260 Dutch.

3

Indinavir crystallization around the loop of Henle: experimental evidence.

Dieleman JP, Salahuddin S, Hsu YS, Burger DM, Gyssens IC, Sturkenboom MC, Stricker BH, Kok DJ. Dieleman JP, et al. J Acquir Immune Defic Syndr. 2001 Sep 1;28(1):9-13. doi: 10.1097/00042560-200109010-00002. J Acquir Immune Defic Syndr. 2001. PMID: 11579271

4

Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA cohort.

Dieleman JP, Jambroes M, Gyssens IC, Sturkenboom MC, Stricker BH, Mulder WM, de Wolf F, Weverling GJ, Lange JM, Reiss P, Brinkman K; ATHENA Study Group. Dieleman JP, et al. AIDS. 2002 Mar 29;16(5):737-45. doi: 10.1097/00002030-200203290-00009. AIDS. 2002. PMID: 11964530

5

Low risk of treatment failure after substitution of nevirapine for protease inhibitors among human immunodeficiency virus-infected patients with virus suppression.

Dieleman JP, Sturkenboom MC, Wit FW, Jambroes M, Mulder JW, Ten Veen JH, Juttmann J, Stricker BH, Lange JM, Van Der Ende ME; AIDS Therapy Evaluation, The Netherlands Study Group (ATHENA). Dieleman JP, et al. J Infect Dis. 2002 May 1;185(9):1261-8. doi: 10.1086/340131. Epub 2002 Apr 16. J Infect Dis. 2002. PMID: 12001043

6

Risk factors for urological symptoms in a cohort of users of the HIV protease inhibitor indinavir sulfate: the ATHENA cohort.

Dieleman JP, Sturkenboom MC, Jambroes M, Gyssens IC, Weverling GJ, ten Veen JH, Schrey G, Reiss P, Stricker BH; Athena Study Group. Dieleman JP, et al. Arch Intern Med. 2002 Jul 8;162(13):1493-501. doi: 10.1001/archinte.162.13.1493. Arch Intern Med. 2002. PMID: 12090886 Clinical Trial.

7

Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project.

Verhamme KM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MC, Artibani W, Begaud B, Berges R, Borkowski A, Chappel CR, Costello A, Dobronski P, Farmer RD, Jiménez Cruz F, Jonas U, MacRae K, Pientka L, Rutten FF, van Schayck CP, Speakman MJ, Sturkenboom MC, Tiellac P, Tubaro A, Vallencien G, Vela Navarrete R; Triumph Pan European Expert Panel. Verhamme KM, et al. Among authors: dieleman jp. Eur Urol. 2002 Oct;42(4):323-8. doi: 10.1016/s0302-2838(02)00354-8. Eur Urol. 2002. PMID: 12361895

8

Persistent leukocyturia and loss of renal function in a prospectively monitored cohort of HIV-infected patients treated with indinavir.

Dieleman JP, van Rossum AM, Stricker BC, Sturkenboom MC, de Groot R, Telgt D, Blok WL, Burger DM, Blijenberg BG, Zietse R, Gyssens IC. Dieleman JP, et al. J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):135-42. doi: 10.1097/00126334-200302010-00004. J Acquir Immune Defic Syndr. 2003. PMID: 12571522

9

Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project.

Verhamme KM, Dieleman JP, Bleumink GS, Bosch JL, Stricker BH, Sturkenboom MC. Verhamme KM, et al. Among authors: dieleman jp. Eur Urol. 2003 Nov;44(5):539-45. doi: 10.1016/s0302-2838(03)00376-2. Eur Urol. 2003. PMID: 14572751

10

Underutilization of preventive strategies in patients receiving NSAIDs.

Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL. Sturkenboom MC, et al. Among authors: dieleman jp. Rheumatology (Oxford). 2003 Nov;42 Suppl 3:iii23-31. doi: 10.1093/rheumatology/keg495. Rheumatology (Oxford). 2003. PMID: 14585915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page